1. Baber MD. A case of congenital cirrhosis of the liver with renal tubular defects akin to those in Fanconi syndrome. Arch Dis Child. 1956;31:335-339.
3. DeBraeleleer M, Larochelle J. Genetic epidemiology of hereditary tyrosinemia in Quebec and Saguenay-Lac Stjean. Am JHum Genet. 1990;47:302-307.
4.
4. Bergeron P, Laberge C, Grenier A. Hereditary tyrosinemia in the province of Quebec: prevalence at birth and geographic distribution. Clin Genet. 1974;5:157-162.
5.
5. Partington MW, Delahaye DJ, Masotti RE, et al. Neonatal tyrosinemia: a follow-up study. Arch Dis Child. 1968; 43:195-199.
6.
6. Driscoll DJ, Jabs EW, Alcorn D, et al. Corneal tyrosine crystals in transient neonatal tyrosinemia. J Pediatr. 1988;113:91-93.
7.
7. Stoner E, Starkman H, Wellner D, et al. Biochemical studies of a patient with tyrosinemia: evidence of glutathione deficiency. Pediatr Res. 1984;18:1332-1336.
8.
8. Russo P, O'Regan S. Visceral pathology of hereditary tyrosinemia type 1. Am JHum Genet. 1990;47:317-324.
9.
9. Strife CF, Zuroweste EL, Emmet EA, et al. Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels. J Pediatr. 1977;90:400-404.
10.
10. Halvorsen S. Tyrosinemia. In: Fernandes J, Saudubray JM, Tada E, eds. Inborn Metabolic Disease: Diagnosis and Treatment. Berlin: Springer Verlag; 1990:199-209.
11.
11. Weinberg AG, Mize CE, Worthen HG. The occurrence of hepatoma in the chronic form of hereditary tyrosine-mia.J Pediatr1976;88:434-438.
12.
12. Cohen BE, Keren G, Horwitz A, et al. Congenital tyrosinemia. Monogr Hum Genet. 1978;9:118-122.
13.
13. van Spronsen FJ, Smit GPA, Wijburg FA, et al. Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation. J Inherit Metab Dis. 1995;18:111-114.
14.
14. Grant M, Larochelle J, Lambert M, et al. Neurologic crisis in hereditary tyrosinemia. N Engl J Med. 1990;322:432-437.
15.
15. Laine J, Salo MK, Krogerus L, et al. The nephropathy of type I tyrosinemia after liver transplantation. Pediatr Res. 1995;37:640-645.
16.
16. Lindstedt S, Holme E, Lock EA, et al. Treatment of hereditary tyrosinemia type I by inhibition of 4-hydroylphenylpyruvate dioxygenase. Lancet. 1992;340:813-817.
17.
17. Holme E, Lindstedt S. Diagnosis and management of tyrosinemia type I. Curr Opin Pediatr1995;7:726-732.
18.
18. Holme E, Lindstedt S. Nontransplant treatment of tyrosinemia. Clin Liver Dis. 2000;4:805-814.
19.
19. van Spronsen FJ, Thomasse Y, Smit GPA, et al. Hereditary tyrosinemia type 1: a new clinical classification with difference in prognosis on dietary treatment. Hepatology. 1994;20:1187-1191.
20.
20. Paradis K, Mitchell G, Russo P. Tvrosinemia. In: Suchy FJ, ed. Liver Disease in Children. St. Louis, MO: Mosby; 1994:803-818.
